scispace - formally typeset
P

Pere P. Simarro

Researcher at World Health Organization

Publications -  46
Citations -  4226

Pere P. Simarro is an academic researcher from World Health Organization. The author has contributed to research in topics: African trypanosomiasis & Trypanosomiasis. The author has an hindex of 29, co-authored 44 publications receiving 3774 citations.

Papers
More filters
Journal ArticleDOI

Eliminating human African trypanosomiasis: where do we stand and what comes next?

TL;DR: While the number of new detected cases of HAT is falling, say the authors, sleeping sickness could suffer the "punishment of success," receiving lower priority by public and private health institutions.
Journal ArticleDOI

The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward.

TL;DR: The World Health Organization (WHO) Expert Committee on HAT Control and Surveillance held in 1995, in consideration of the huge uncertainties between the reported cases and the factual field situation, estimated that the true number of cases was at least 10 times more than reported.
Journal ArticleDOI

The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases

TL;DR: Although efforts are still needed to reduce the number of undetected and unreported cases, the comprehensive, village-level mapping of HAT control activities over a ten-year period ensures a detailed and reliable representation of the known geographic distribution of the disease.
Journal ArticleDOI

Epidemiology of human African trypanosomiasis

TL;DR: Sustainable elimination of the gambiense HAT, defined as the interruption of the transmission of the disease, was considered as a feasible target for 2030, since rhodesiense H AT is a zoonosis, where the animal reservoir plays a key role, and the interruptionOf the disease’s transmission is not deemed feasible.
Journal ArticleDOI

Options for Field Diagnosis of Human African Trypanosomiasis

TL;DR: There is an urgent need for better tools for the field diagnosis of this neglected disease, and improved access to diagnosis and treatment for the population at risk remains the greatest challenge for the coming years.